Sindrome de Sjogren primario: aspectos clinicos e inmunologicos

Sanchez Contreras, Alvaro; Chalem B., Fernando.
Acta méd. colomb ; 12(1): 3-14, ene.-feb. 1987. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-70168

Documentos relacionados

  1. Sjögren syndrome.
  2. Mediterranean diet and risk of Sjögren's syndrome.
  3. [ORGAN-SPECIFIC AND ORGAN-NONESPECIFIC AUTOANTIBODIES AND DAMAGE OF ORGANS AND SYSTEMS AT SJOGREN'S SYNDROME].
  4. Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications.
  5. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
  6. Anti-citrullinated protein antibodies and arthritis in Sjögren's syndrome: a systematic review and meta-analysis.
  7. Epigenetic alterations in primary Sjögren's syndrome - an overview.
  8. Rethinking Sjögren Beyond Inflammation: Considering the Role of Nerves in Driving Disease Manifestations.
  9. Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren's syndrome.
  10. Dry skin manifestations in Sjögren syndrome and atopic dermatitis related to aberrant sudomotor function in inflammatory allergic skin diseases.